Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
HPV-related oropharyngeal cancer prevalence in a middle eastern population using E6/E7 PCR
Majority of patients (85.3%) tested positive for HPV DNA.
»
01/06/20
A cross sectional study to determine the prevalence of cough and its impact in patients with lung cancer: a patient unmet need
Fewer patients on treatment reported cough (40%) compared to those off treatment (54%).
»
01/06/20
A pre-existing population of ZEB2 + quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
Increased ZEB2 levels correlated with worse relapse-free survival.
»
01/08/20
Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation
Trans-differentiation manifested by upregulation of basal keratins.
»
01/07/20
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells
Administration of anti-PD-1 antibody decreased Treg within tumour.
»
01/08/20
Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study
Most common adverse events hematologic toxicities and gastrointestinal effects.
»
01/08/20
An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer
Simulations show that increased dose of OXP alone would improve response.
»
01/08/20
LINC00908 negatively regulates microRNA-483-5p to increase TSPYL5 expression and inhibit the development of prostate cancer
Overexpression of LINC00908 inhibited tumor growth of PCa.
»
01/09/20
A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
CSC markers ALDH+ and CD24− and CD44+ measured by flow cytometry decreased by ≥ 20%.
»
01/10/20
Childhood cancer incidence and survival trends in Estonia (1970–2016): a nationwide population-based study
Overall 5-year survival improved from 24% in 1970–1979 to 73% in 2010–2016.
»
01/10/20
< Prev
Next >